{
    "code": "01016671",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01016671",
    "time": "2020-02-25 02:37:19",
    "許可證字號": "衛署藥製字第016671號",
    "註銷狀態": "已註銷",
    "註銷日期": "76\/06\/02",
    "註銷理由": "安用科更新資料",
    "有效日期": "75\/02\/12",
    "發證日期": "68\/02\/12",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "null",
    "中文品名": "&quot;北進&quot; 逸舒寧膠囊（氯普賽）",
    "英文品名": "SEDALIUM CAPSULES (CHLORDIAZEPOXIDE) &quot;P.J.&quot;",
    "適應症": "精神不安症、緊張症、焦躁感、不眠症、肌肉痙攣",
    "劑型": "130膠囊劑",
    "包裝": "瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 34第四級管制藥品",
        "申請商名稱": "0511504200  北進製藥股份有限公司",
        "申請商地址": "桃園市龜山區南上路５２２號",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2824200210",
            "成分名稱": "CHLORDIAZEPOXIDE HCL",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ]
}